Prednisone Taper for Bell's Palsy
For Bell's palsy in patients ≥16 years old, initiate prednisone 60 mg daily for 5 days, then taper by 10 mg daily over the next 5 days (total 10-day course), starting within 72 hours of symptom onset. 1
Initial Dosing and Timing
The evidence-based approach is straightforward:
- Start dose: 60 mg prednisone (or 50 mg prednisolone) daily
- Timing: Must begin within 72 hours of facial weakness onset for maximum benefit
- Administration: Take in the morning (before 9 AM) with food to minimize gastric irritation 2
The American Academy of Otolaryngology guidelines strongly recommend this regimen based on two high-quality randomized controlled trials (Sullivan et al. and Engstrom et al.) showing 94.4% recovery at 9 months with prednisolone versus 81.6% with placebo 1, 3. Treatment after 72 hours has unclear benefit 1.
Specific Taper Schedule
Days 1-5: 60 mg daily (single morning dose)
Days 6-10: Reduce by 10 mg each day:
- Day 6: 50 mg
- Day 7: 40 mg
- Day 8: 30 mg
- Day 9: 20 mg
- Day 10: 10 mg
This 10-day total duration with 5 days at high dose followed by 5-day taper is the evidence-based standard 1, 4. An alternative acceptable regimen is prednisolone 25 mg twice daily for 10 days without taper 1.
Adjustments for Comorbidities
Diabetes: Exercise caution with shared decision-making. Monitor blood glucose closely as corticosteroids will elevate levels. The guideline specifically notes diabetes as an exception requiring individualized assessment 1. Consider the severity of Bell's palsy—severe cases (House-Brackmann grade 4-6) benefit most from treatment 4, 5.
Morbid obesity: Similar caution warranted with shared decision-making 1. The metabolic effects of steroids are amplified, but complete facial paralysis carries significant quality-of-life implications.
Previous steroid intolerance: This is a contraindication 1. Do not use corticosteroids if prior adverse reactions occurred.
Pregnancy: Requires individualized assessment 1. Natural recovery rates in pregnant women approach 90%, so the risk-benefit calculation differs 6.
Peptic ulcer disease or GERD: Administer antacids between meals when using high-dose steroids 2. Consider proton pump inhibitor prophylaxis.
Hypertension: Monitor blood pressure; dietary salt restriction advisable 2.
Critical Pitfalls to Avoid
Do not abruptly discontinue: The FDA label explicitly warns against abrupt withdrawal 2. Always complete the taper even if symptoms improve.
Do not use antivirals alone: Antiviral monotherapy (valacyclovir, acyclovir) without steroids is ineffective and strongly discouraged 1, 3. The Engstrom trial showed no benefit of valacyclovir on recovery time (HR 1.01, p=0.90) 3.
Do not delay treatment: Each day of delay worsens prognosis. Treatment initiated >7 days after onset has an 18-fold increased risk of poor outcome 4.
Severity matters: Patients with severe paralysis (House-Brackmann grade 4-6), hearing deficits, or recurrent Bell's palsy have worse prognoses and need aggressive treatment 4.
Optional Combination Therapy
Combination steroid + antiviral therapy may be offered (not required) within 72 hours, particularly for severe cases 1. If choosing combination:
- Valacyclovir 1000 mg three times daily for 7 days, OR
- Acyclovir 400 mg five times daily for 10 days 6
The evidence is mixed—some smaller trials suggest reduced synkinesis rates with combination therapy 1, 7, but large trials show no significant benefit 3. This requires shared decision-making with patients.
Pediatric Considerations
For children <16 years: Evidence is insufficient, but steroids may be considered given similar pathophysiology and favorable safety profile 1. Use the same dosing regimen with significant caregiver involvement in decision-making.
No Taper Needed for Short Courses
The 10-day course with built-in taper is sufficient. Do not extend beyond 10 days unless treating a different condition. The short duration minimizes HPA axis suppression while maximizing facial nerve recovery 2.